1. CHEEVER, M.A., POTENTIAL FOR SPECIFIC CANCER-THERAPY WITH IMMUNE LYMPHOCYTES-T, JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS 3: 113 (1984).
2. CHEEVER, M.A., AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2, JOURNAL OF EXPERIMENTAL MEDICINE 155: 968 (1982).
3. CHEEVER, M.A., INTERLEUKIN-2 ADMINISTERED INVIVO INDUCES THE GROWTH OF CULTURED T-CELLS INVIVO, JOURNAL OF IMMUNOLOGY 132: 2259 (1984).
4. DONOHUE, J.H., THE FATE OF INTERLEUKIN-2 AFTER INVIVO ADMINISTRATION, JOURNAL OF IMMUNOLOGY 130: 2203 (1983).
5. DONOHUE, J.H., THE SYSTEMIC ADMINISTRATION OF PURIFIED INTERLEUKIN-2 ENHANCES THE ABILITY OF SENSITIZED MURINE LYMPHOCYTES TO CURE A DISSEMINATED SYNGENEIC LYMPHOMA, JOURNAL OF IMMUNOLOGY 132: 2123 (1984).